Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 6:13:865425.
doi: 10.3389/fimmu.2022.865425. eCollection 2022.

Proteome Profiling Identifies Serum Biomarkers in Rheumatoid Arthritis

Congqi Hu  1 , Zhao Dai  2 , Jia Xu  2 , Lianyu Zhao  2 , Yanping Xu  3 , Meilin Li  2 , Jiahui Yu  2 , Lu Zhang  2 , Hui Deng  2 , Lijuan Liu  1 , Mingying Zhang  1 , Jiarong Huang  4 , Linping Wu  4 , Guangxing Chen  1   3
Affiliations

Proteome Profiling Identifies Serum Biomarkers in Rheumatoid Arthritis

Congqi Hu et al. Front Immunol. .

Abstract

Rheumatoid arthritis (RA) causes serious disability and productivity loss, and there is an urgent need for appropriate biomarkers for diagnosis, treatment assessment, and prognosis evaluation. To identify serum markers of RA, we performed mass spectrometry (MS)-based proteomics, and we obtained 24 important markers in normal and RA patient samples using a random forest machine learning model and 11 protein-protein interaction (PPI) network topological analysis methods. Markers were reanalyzed using additional proteomics datasets, immune infiltration status, tissue specificity, subcellular localization, correlation analysis with disease activity-based diagnostic indications, and diagnostic receiver-operating characteristic analysis. We discovered that ORM1 in serum is significantly differentially expressed in normal and RA patient samples, which is positively correlated with disease activity, and is closely related to CD56dim natural killer cell, effector memory CD8+T cell, and natural killer cell in the pathological mechanism, which can be better utilized for future research on RA. This study supplies a comprehensive strategy for discovering potential serum biomarkers of RA and provides a different perspective for comprehending the pathological mechanism of RA, identifying potential therapeutic targets, and disease management.

Keywords: ORM1; biomarker; proteomics; rheumatoid arthritis; serum.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Schematic diagram about the analysis of RA potential proteins based on LC-MS proteomics. (A) Identification of differentially expressed proteins. (B) Multiple-analysis methods to assess the importance of differentially expressed proteins.
Figure 2
Figure 2
Identification of differentially expressed proteins. (A) Random forest machine learning method combined with the PPI network importance analysis algorithm to screen differential proteins. (B) Enrichment results of 24 differential proteins. The blue size represents the number of counts corresponding to the result.
Figure 3
Figure 3
Combine other proteomics datasets to analyze differential proteins. (A) Crossover situation in 5 proteomics datasets. (B) Visually display differential proteins co-expressed (greater than 2) in multiple proteomics datasets. Different shapes and colors represent different datasets. (C, D) Enrichment results of 30 differential proteins in 5 proteomics datasets. The green size represents the number of counts corresponding to the result.
Figure 4
Figure 4
Multi-angle analysis of 24 differentially expressed proteins. (A) Immune infiltration analysis protein expression in 23 immune cells in healthy controls and RA patient. (B) Correlation analysis of 24 proteins with statistically significant immune cells. (C) Tissue specificity of 24 differential proteins. (D) Subcellular localization of 24 differential proteins. *p < 0.05, **p < 0.01, ***p < 0.001. ns, no significance.
Figure 5
Figure 5
Correlation analysis between RA laboratory diagnostic indicators and disease activity. Positive and negative signs indicate the direction of the correlation. A positive sign indicates a positive correlation (red), and a negative sign indicates a negative correlation (blue). *p < 0.05, **p < 0.01.
Figure 6
Figure 6
Summarize a variety of analysis methods to select the most meaningful protein as the key protein of RA.
See this image and copyright information in PMC

References

    1. Tobón GJ, Youinou P, Saraux A. The Environment, Geo-Epidemiology, and Autoimmune Disease: Rheumatoid Arthritis. J Autoimmun (2010) 35:10–4. doi: 10.1016/j.jaut.2009.12.009 - DOI - PubMed
    1. Glick EN. Immunopathogenesis of Rheumatoid Arthritis. J R Soc Med (1980) 73:80. doi: 10.1177/014107688007300129 - DOI
    1. Nies J, Krabben A, Schoones JW, Huizinga T, Kloppenburg M, Mil A.H.M.V.D.H.-V. What is the Evidence for the Presence of a Therapeutic Window of Opportunity in Rheumatoid Arthritis? A Systematic Literature Review. Ann Rheumat Dis (2014) 73:861–70. doi: 10.1136/annrheumdis-2012-203130 - DOI - PubMed
    1. Wells G, Li T, Maxwell L, Maclean R, Tugwell P. Responsiveness of Patient Reported Outcomes Including Fatigue, Sleep Quality, Activity Limitation, and Quality of Life Following Treatment With Abatacept for Rheumatoid Arthritis. Ann Rheumat Dis (2008) 67:260–5. doi: 10.1136/ard.2007.069690 - DOI - PubMed
    1. Kroot EJJA, Jong B, Leeuwen M, Swinkels H, Hoogen F.H.J.V.D., Hof MVT, et al. The Prognostic Value of Anti-Cyclic Citrullinated Peptide Antibody in Patients With Recent-Onset Rheumatoid Arthritis. Arthritis Rheumatol (2000) 43:1831–5. doi: 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6 - DOI - PubMed

Publication types